The University of Massachusetts (UMass) Center for Clinical and Translational Science (UMCCTS) was organized with the vision of transforming clinical and translational research (CTR) and education across the five UMass campuses and our clinical partner, UMass Memorial Health Care (UMMHC). Specific goals were to leverage our scientific strengths and unique resources: 1) to accelerate the translation of discoveries into practical, cost effective solutions that improve human health; and 2) to train the next generation of leaders in CTR. Over the past five years, the UMCCTS has fostered a culture of trans-disciplinary collaboration; provided cores, services, and pilot programs; and developed innovative educational and training programs. We have capitalized on our outstanding basic science research to create an ecosystem that accelerates early phase translation and have facilitated the development of nationally recognized programs in community engagement, health disparities, outcomes, and Global Health. Public-private partnerships have positioned UMass campuses as hubs in the Massachusetts (MA) innovation economy. We will continue to build the UMCCTS for statewide, national, and international collaboration and impact by: 1. Building and supporting an innovative and collaborative translational workforce with the knowledge and expertise to advance high impact CTR. Using an active approach to solving real-world problems that combines didactic education, experiential training, and integrated mentorship to facilitate team science, we will expand CTR educational and training opportunities through revamped curricula, a new PhD and postdoctoral training program (linked TL1 award), an enhanced KL2 Scholars program, increased training opportunities and career support for our entire CTR workforce; 2. Engaging stakeholders to build enabling systems and trans- disciplinary teams that provide the scientific expertise, funding, processes, and tools conducive to effective CTR. We will continue to expand public-private partnerships that build out the UMCCTS as a contributing partner in the national CTSA network; we will particularly work to build capacity to identify and advance products for clinical development. We will also collaborate with the CTSA network on testing new approaches to improving the design, completion, and reporting of clinical trials that result in improved population, community, and global health; 3. Integrating translational science across its multiple phases, diverse disciplines, within disadvantaged populations, and across the lifespan. We will capitalize on specific expertise in disparities, LGBT, pediatric, and geriatric research along with successes in community engagement to maximize the impact of our work on health improvement at the local, national, and global levels. 4. Testing new approaches to develop and evaluate the impact of policies, processes, and platforms that support innovation, quality, safety, and efficiency in CTR. Project Summary/Abstract Page 158 Contact PD/PI: Luzuriaga, Katherine

Public Health Relevance

The University of Massachusetts Center for Clinical and Translational Science (UMCCTS) will provide innovative education and career development programs, catalytic pilot grant programs, and cost-effective services and facilities that accelerate the translation of discoveries into practical solutions that improve human health. Project Narrative Page 159

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001453-01S1
Application #
9137978
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Purucker, Mary E
Project Start
2015-08-14
Project End
2019-03-31
Budget Start
2015-09-11
Budget End
2016-03-31
Support Year
1
Fiscal Year
2015
Total Cost
$13,590
Indirect Cost
$3,597
Name
University of Massachusetts Medical School Worcester
Department
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Byatt, Nancy; Cox, Lucille; Moore Simas, Tiffany A et al. (2018) Access to Pharmacotherapy Amongst Women with Bipolar Disorder during Pregnancy: a Preliminary Study. Psychiatr Q 89:183-190
Mayasi, Yunis; Helenius, Johanna; McManus, David D et al. (2018) Atrial fibrillation is associated with anterior predominant white matter lesions in patients presenting with embolic stroke. J Neurol Neurosurg Psychiatry 89:6-13
Walter, Angela Wangari; Morocho, Cesar; King, Lauren et al. (2018) Preventing Opioid Use Disorders among Fishing Industry Workers. Int J Environ Res Public Health 15:
Tzeng, Te-Chen; Hasegawa, Yuto; Iguchi, Risa et al. (2018) Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice. Proc Natl Acad Sci U S A 115:9002-9007
Silfee, Valerie J; Haughton, Christina F; Jake-Schoffman, Danielle E et al. (2018) Objective measurement of physical activity outcomes in lifestyle interventions among adults: A systematic review. Prev Med Rep 11:74-80
Khubchandani, Jasmine; Soni, Apurv; Fahey, Nisha et al. (2018) Caste matters: perceived discrimination among women in rural India. Arch Womens Ment Health 21:163-170
Waring, Molly E; Moore Simas, Tiffany A; Oleski, Jessica et al. (2018) Feasibility and Acceptability of Delivering a Postpartum Weight Loss Intervention via Facebook: A Pilot Study. J Nutr Educ Behav 50:70-74.e1
Momen-Heravi, Fatemeh; Bala, Shashi (2018) Extracellular vesicles in oral squamous carcinoma carry oncogenic miRNA profile and reprogram monocytes via NF-?B pathway. Oncotarget 9:34838-34854
Kahn, Peter A; Trivedi, Michelle; Ramadan, Amira A et al. (2018) A Community-Based Pilot Survey of Pediatric Food Allergies in a Maryland Orthodox Jewish Community. Clin Pediatr (Phila) 57:1236-1238
Sreedhara, Meera; Silfee, Valerie J; Rosal, Milagros C et al. (2018) Does provider advice to increase physical activity differ by activity level among US adults with cardiovascular disease risk factors? Fam Pract 35:420-425

Showing the most recent 10 out of 163 publications